Dosing of losartan in men versus women with heart failure with reduced ejection fraction: the HEAAL trial.
- DOI
- 10.1002/ejhf.2255
- Published
- 2021 Sep
- Container
- European journal of heart failure
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/ejhf.2255,
title = {Dosing of losartan in men versus women with heart failure with reduced ejection fraction: the HEAAL trial.},
author = {Ferreira JP and Konstam MA and McMurray JJV and Butler J and Girerd N and Rossignol P and Sharma A and Voors AA and Lam CSP and Packer M and Zannad F},
year = {2021},
journal = {European journal of heart failure},
doi = {10.1002/ejhf.2255},
url = {https://doi.org/10.1002/ejhf.2255}
}RIS
TY - JOUR TI - Dosing of losartan in men versus women with heart failure with reduced ejection fraction: the HEAAL trial. AU - Ferreira JP AU - Konstam MA AU - McMurray JJV AU - Butler J AU - Girerd N AU - Rossignol P AU - Sharma A AU - Voors AA AU - Lam CSP AU - Packer M AU - Zannad F PY - 2021 JO - European journal of heart failure DO - 10.1002/ejhf.2255 UR - https://doi.org/10.1002/ejhf.2255 ER -
APA
JP, F., MA, K., JJV, M., J, B., N, G., P, R., A, S., AA, V., CSP, L., M, P., & F, Z. (2021). Dosing of losartan in men versus women with heart failure with reduced ejection fraction: the HEAAL trial.. European journal of heart failure. https://doi.org/10.1002/ejhf.2255
Source records
- pubmed · retrieved 2026-11-10T18:07:30.514Z